What's in Astellas Pharma Europe Ltd.'s pipeline?

Astellas Pharma Europe Ltd. has 5 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with Astellas Pharma Europe Ltd.'s portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Allergan, Andrew B Adams, Armando Torres Ramírez, Albert Einstein Healthcare Network.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/astellas-pharma-europe-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Astellas Pharma Europe Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Astellas Pharma Europe Ltd. pipeline: 1 marketed, 0 filed, 1 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Eligard	Eligard	marketed		Gonadotropin-releasing hormone receptor, Gonadotropin-releasing hormone receptor	Oncology
FK506E	FK506E	phase 3	Calcineurin inhibitor	Calcineurin (protein phosphatase 2B)	Immunology

Therapeutic area mix

Immunology · 1
Oncology · 1
Urology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 2 shared drug classes
Allergan · 1 shared drug class
Andrew B Adams · 1 shared drug class
Armando Torres Ramírez · 1 shared drug class
Albert Einstein Healthcare Network · 1 shared drug class
Astellas Pharma China, Inc. · 1 shared drug class
Astellas Pharma Inc · 1 shared drug class
Al-Azhar University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Astellas Pharma Europe Ltd.:

Cite this brief

Drug Landscape (2026). Astellas Pharma Europe Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/astellas-pharma-europe-ltd. Accessed 2026-05-16.